0001209191-21-024103.txt : 20210401 0001209191-21-024103.hdr.sgml : 20210401 20210401162000 ACCESSION NUMBER: 0001209191-21-024103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210401 FILED AS OF DATE: 20210401 DATE AS OF CHANGE: 20210401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bergstrom Donald A CENTRAL INDEX KEY: 0001709772 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39344 FILM NUMBER: 21798329 MAIL ADDRESS: STREET 1: 840 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fusion Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001805890 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 270 LONGWOOD ROAD SOUTH CITY: HAMILTON STATE: A6 ZIP: L8P 0A6 BUSINESS PHONE: 289-799-0891 MAIL ADDRESS: STREET 1: 270 LONGWOOD ROAD SOUTH CITY: HAMILTON STATE: A6 ZIP: L8P 0A6 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-01 0 0001805890 Fusion Pharmaceuticals Inc. FUSN 0001709772 Bergstrom Donald A C/O FUSION PHARMACEUTICALS, INC. 2 INTERNATIONAL PLACE, SUITE 2310 BOSTON MA 02110 1 0 0 0 Stock Option (Right to Buy) 10.59 2021-04-01 4 A 0 34000 0.00 A 2031-04-01 Common Stock 34000 34000 D The shares subject to this option shall vest and become exercisable in 36 substantially equal monthly installments starting on May 1, 2021. /s/Maria Stahl as Attorney-in-Fact 2021-04-01